{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:28:37Z","timestamp":1789475317486,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12944-015-0096-0","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T19:15:23Z","timestamp":1442430923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Association of serum lipid levels and prostate cancer severity among Hispanic Puerto Rican men"],"prefix":"10.1186","volume":"14","author":[{"given":"Jeannette","family":"Salgado-Montilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marievelisse","family":"Soto Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Surillo Trautmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"S\u00e1nchez-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Irizarry-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,17]]},"reference":[{"key":"96_CR1","volume-title":"Cancer in Puerto Rico, 2008\u20132012. Puerto Rico Central Cancer Registry","author":"G Tortolero Luna","year":"2013","unstructured":"Tortolero Luna G, Zaval ZD, P\u00e9rez R\u00edos N, Torres Cintr\u00f3n CR, Ortiz Ortiz KJ, Traverso Ortiz M, et al. Cancer in Puerto Rico, 2008\u20132012. Puerto Rico Central Cancer Registry. PR: San Juan; 2013."},{"key":"96_CR2","unstructured":"Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, et al.. SEER Cancer Statistics Review, 1975\u20132010. In Book SEER Cancer Statistics Review, 1975\u20132010 (Editor ed.^eds.), based on November 2012 SEER data submission edition. City; 2013."},{"key":"96_CR3","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3322\/caac.21153","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics for Hispanics\/Latinos, 2012. CA Cancer J Clin. 2012;62:283\u201398.","journal-title":"CA Cancer J Clin"},{"key":"96_CR4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10\u201329.","journal-title":"CA Cancer J Clin"},{"key":"96_CR5","first-page":"107","volume":"31","author":"M Soto-Salgado","year":"2012","unstructured":"Soto-Salgado M, Suarez E, Torres-Cintron M, Pettaway CA, Colon V, Ortiz AP. Prostate cancer incidence and mortality among Puerto Ricans: an updated analysis comparing men in Puerto Rico with US racial\/ethnic groups. P R Health Sci J. 2012;31:107\u201313.","journal-title":"P R Health Sci J"},{"key":"96_CR6","unstructured":"National Cancer Institute. PDQ\u00ae Prostate Cancer Prevention [ http:\/\/www.cancer.gov\/types\/prostate\/patient\/prostate-prevention-pdq ]. Accessed 07\/23\/2015."},{"key":"96_CR7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0009-8981(03)00048-2","volume":"330","author":"MS Willis","year":"2003","unstructured":"Willis MS, Wians FH. The role of nutrition in preventing prostate cancer: a review of the proposed mechanism of action of various dietary substances. Clin Chim Acta Int J Clin Chem. 2003;330:57\u201383.","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"96_CR8","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.eururo.2012.11.013","volume":"63","author":"EH Allott","year":"2013","unstructured":"Allott EH, Masko EM, Freedland SJ. Obesity and prostate cancer: weighing the evidence. Eur Urol. 2013;63:800\u20139.","journal-title":"Eur Urol"},{"key":"96_CR9","first-page":"345","volume":"10","author":"C Rodriguez","year":"2001","unstructured":"Rodriguez C, Patel AV, Calle EE, Jacobs EJ, Chao A, Thun MJ. Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev. 2001;10:345\u201353.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"96_CR10","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1002\/cncr.25539","volume":"116","author":"T Zilli","year":"2010","unstructured":"Zilli T, Chagnon M, Van Nguyen T, Bahary JP, Guay JP, Dufresne A, et al. Influence of abdominal adiposity, waist circumference, and body mass index on clinical and pathologic findings in patients treated with radiotherapy for localized prostate cancer. Cancer. 2010;116:5650\u20138.","journal-title":"Cancer"},{"key":"96_CR11","unstructured":"Behavioral Risk Factor Surveillance System Survey Data. In Book Behavioral Risk Factor Surveillance System Survey Data (Editor ed.^eds.). City: Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC); 2012."},{"key":"96_CR12","first-page":"434","volume":"18","author":"CM Perez","year":"2008","unstructured":"Perez CM, Guzman M, Ortiz AP, Estrella M, Valle Y, Perez N, et al. Prevalence of the metabolic syndrome in San Juan, Puerto Rico. Ethn Dis. 2008;18:434\u201341.","journal-title":"Ethn Dis"},{"issue":"S1","key":"96_CR13","first-page":"168","volume":"20","author":"R Negron","year":"2010","unstructured":"Negron R, Vasquez A, Nieves M, Guerrios L, Irizarry-Ramirez M. Body mass index affects the diagnosis and progression of prostate cancer in Hispanics. Ethn Dis. 2010;20(S1):168\u201372.","journal-title":"Ethn Dis"},{"key":"96_CR14","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.juro.2009.07.039","volume":"182","author":"KA Moses","year":"2009","unstructured":"Moses KA, Abd TT, Goodman M, Hsiao W, Hall JA, Marshall FF, et al. Increased low density lipoprotein and increased likelihood of positive prostate biopsy in black americans. J Urol. 2009;182:2219\u201325.","journal-title":"J Urol"},{"key":"96_CR15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4103\/1119-3077.100623","volume":"15","author":"KS Adedapo","year":"2012","unstructured":"Adedapo KS, Arinola OG, Shittu OB, Kareem OI, Okolo CA, Nwobi LN. Diagnostic value of lipids, total antioxidants, and trace metals in benign prostate hyperplasia and prostate cancer. Niger J Clin Pract. 2012;15:293\u20137.","journal-title":"Niger J Clin Pract"},{"key":"96_CR16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1464-410X.2011.10358.x","volume":"109","author":"N Hayashi","year":"2012","unstructured":"Hayashi N, Matsushima M, Yamamoto T, Sasaki H, Takahashi H, Egawa S. The impact of hypertriglyceridemia on prostate cancer development in patients aged >\/=60\u00a0years. BJU Int. 2012;109:515\u20139.","journal-title":"BJU Int"},{"issue":"11","key":"96_CR17","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1158\/1055-9965.EPI-09-0472","volume":"18","author":"EA Platz","year":"2009","unstructured":"Platz EA, Till C, Goodman PJ, Parnes HL, Figg WD, Albanes D, et al. Men with Low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo Arm of the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev. 2009;18(11):2807\u201313. doi: 10.1158\/1055-9965.EPI-09-0472Men .","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"96_CR18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.tem.2007.12.004","volume":"19","author":"KR Solomon","year":"2008","unstructured":"Solomon KR, Freeman MR. Do the cholesterol-lowering properties of statins affect cancer risk? Trends Endocrinol Metab. 2008;19:113\u201321.","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"96_CR19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10552-009-9434-8","volume":"21","author":"AM Mondul","year":"2010","unstructured":"Mondul AM, Clipp SL, Helzlsouer KJ, Platz EA. Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort. Cancer Causes Control. 2010;21(1):61\u20138. doi: 10.1007\/s10552-009-9434-8 .","journal-title":"Cancer Causes Control"},{"key":"96_CR20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2217\/pgs.09.5","volume":"10","author":"G Ruano","year":"2009","unstructured":"Ruano G, Duconge J, Windemuth A, Cadilla CL, Kocherla M, Villagra D, et al. Physiogenomic analysis of the Puerto Rican population. Pharmacogenomics. 2009;10:565\u201377.","journal-title":"Pharmacogenomics"},{"key":"96_CR21","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1002\/cncr.27677","volume":"118","author":"C Haggstrom","year":"2012","unstructured":"Haggstrom C, Stocks T, Ulmert D, Bjorge T, Ulmer H, Hallmans G, et al. Prospective study on metabolic factors and risk of prostate cancer. Cancer. 2012;118:6199\u2013206.","journal-title":"Cancer"},{"key":"96_CR22","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1002\/cncr.25749","volume":"117","author":"DI Chu","year":"2011","unstructured":"Chu DI, Freedland SJ. Metabolic risk factors in prostate cancer. Cancer. 2011;117:2020\u20133.","journal-title":"Cancer"},{"key":"96_CR23","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/aje\/kwj320","volume":"164","author":"AJ Tande","year":"2006","unstructured":"Tande AJ, Platz EA, Folsom AR. The metabolic syndrome is associated with reduced risk of prostate cancer. Am J Epidemiol. 2006;164:1094\u2013102.","journal-title":"Am J Epidemiol"},{"key":"96_CR24","first-page":"394","volume":"25","author":"GY Ho","year":"2009","unstructured":"Ho GY, Figueroa-Vall\u00e9s NR, De La Torre-Feliciano T, et al. Cancer disparities between mainland and island Puerto Ricans. Rev Panam Salud Publica. 2009;25:394\u201340.","journal-title":"Rev Panam Salud Publica"},{"issue":"4","key":"96_CR25","first-page":"194","volume":"32","author":"V Colon Lopez","year":"2013","unstructured":"Colon Lopez V, Banerjee G, Gertz AM, Ortiz AP, Calo W, Finney-Rutten LJ, et al. Behavioral correlates of fruit and vegetable intake in Puerto Rico: results from the Health Information National Trends Survey. P R Health Sci J. 2013;32(4):194\u20139.","journal-title":"P R Health Sci J"},{"key":"96_CR26","first-page":"145","volume":"30","author":"JM Marcial","year":"2011","unstructured":"Marcial JM, Altieri PI, Banchs H, Escobales N, Crespo M. Metabolic syndrome among Puerto Ricans and other Hispanic populations. P R Health Sci J. 2011;30:145\u201351.","journal-title":"P R Health Sci J"},{"key":"96_CR27","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s10900-013-9726-5","volume":"38","author":"CM Perez","year":"2013","unstructured":"Perez CM, Sanchez H, Ortiz AP. Prevalence of overweight and obesity and their cardiometabolic comorbidities in Hispanic adults living in Puerto Rico. J Community Health. 2013;38:1140\u20136.","journal-title":"J Community Health"},{"key":"96_CR28","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2407-12-25","volume":"12","author":"K Shafique","year":"2012","unstructured":"Shafique K, McLoone P, Qureshi K, Leung H, Hart C, Morrison DS. Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37\u00a0years\u2019 follow up. BMC Cancer. 2012;12:25. doi: 10.1186\/1471-2407-12- .","journal-title":"BMC Cancer"},{"key":"96_CR29","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/cncr.25758","volume":"117","author":"M Hemelrijck Van","year":"2011","unstructured":"Van Hemelrijck M, Garmo H, Holmberg L, Walldius G, Jungner I, Hammar N, et al. Prostate cancer risk in the Swedish AMORIS study. Cancer. 2011;117:2086\u201395. doi: 10.1002\/cncr.25758 .","journal-title":"Cancer"},{"key":"96_CR30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1186\/1471-2458-13-629","volume":"13","author":"P Liu","year":"2013","unstructured":"Liu P, Ma F, Lou H, Liu Y. The utility of fat mass index vs. body mass index and percentage of body fat in the screening of metabolic syndrome. BMC Public Health. 2013;13:629.","journal-title":"BMC Public Health"},{"key":"96_CR31","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.urology.2013.01.021","volume":"81","author":"K Chamie","year":"2013","unstructured":"Chamie K, Oberfoell S, Kwan L, Labo J, Wei JT, Litwin MS. Body mass index and prostate cancer severity: do obese men harbor more aggressive disease on prostate biopsy? Urology. 2013;81:949\u201355.","journal-title":"Urology"},{"key":"96_CR32","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/sj.pcan.4500834","volume":"8","author":"L Wuermli","year":"2005","unstructured":"Wuermli L, Joerger M, Henz S, Schmid HP, Riesen WF, Thomas G, et al. Hypertriglyceridemia as a possible risk factor for prostate cancer. Prostate Cancer Prostatic Dis. 2005;8:316\u201320.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"96_CR33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/1097-0215(20010101)91:1<41::AID-IJC1009>3.0.CO;2-2","volume":"91","author":"Y Chen","year":"2001","unstructured":"Chen Y, Hughes-Fulford M. Human prostate cancer cells lack feedback regulation of low-density lipoprotein receptor and its regulator, SREBP2. Int J Cancer. 2001;91:41\u20135.","journal-title":"Int J Cancer"},{"key":"96_CR34","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00041433-199404000-00006","volume":"5","author":"RJ Havel","year":"1994","unstructured":"Havel RJ. Postprandial hyperlipidemia and remnant lipoproteins. Curr Opin Lipidol. 1994;5:102\u20139.","journal-title":"Curr Opin Lipidol"},{"key":"96_CR35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.canep.2009.04.004","volume":"33","author":"Y Sekine","year":"2009","unstructured":"Sekine Y, Koike H, Nakano T, Nakajima K, Takahashi S, Suzuki K. Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density lipoprotein receptor. Cancer Epidemiol. 2009;33:16\u201323.","journal-title":"Cancer Epidemiol"},{"key":"96_CR36","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.coph.2012.07.006","volume":"12","author":"K Pelton","year":"2012","unstructured":"Pelton K, Freeman MR, Solomon KR. Cholesterol and prostate cancer. Curr Opin Pharmacol. 2012;12:751\u20139.","journal-title":"Curr Opin Pharmacol"},{"issue":"8","key":"96_CR37","doi-asserted-by":"crossref","first-page":"13615","DOI":"10.3390\/ijms150813615","volume":"15","author":"J Morote","year":"2014","unstructured":"Morote J, Celma A, Planas J, et al. Role of serum cholesterol and statin Use in the risk of prostate cancer detection and tumor aggressiveness. Int J Mol Sci. 2014;15(8):13615\u201323. doi: 10.3390\/ijms150813615 .","journal-title":"Int J Mol Sci"},{"key":"96_CR38","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/pcan.2011.30","volume":"14","author":"DE Kok","year":"2011","unstructured":"Kok DE, van Roermund JG, Aben KK, den Heijer M, Swinkels DW, Kampman E, et al. Blood lipid levels and prostate cancer risk; a cohort study. Prostate Cancer Prostatic Dis. 2011;14:340\u20135.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"96_CR39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030062","volume":"7","author":"EA Mostaghel","year":"2012","unstructured":"Mostaghel EA, Solomon KR, Pelton K, Freeman MR, Montgomery RB. Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors. PLoS One. 2012;7, e30062.","journal-title":"PLoS One"},{"key":"96_CR40","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1172\/JCI200519935","volume":"115","author":"L Zhuang","year":"2005","unstructured":"Zhuang L, Kim J, Adam RM, Solomon KR, Freeman MR. Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Invest. 2005;115:959\u201368.","journal-title":"J Clin Invest"},{"key":"96_CR41","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2188\/jea.JE20130006","volume":"23","author":"K Kotani","year":"2013","unstructured":"Kotani K, Sekine Y, Ishikawa S, Ikpot IZ, Suzuki K, Remaley AT. High-density lipoprotein and prostate cancer: an overview. J Epidemiol\/Jap Epidemiol Assoc. 2013;23:313\u20139.","journal-title":"J Epidemiol\/Jap Epidemiol Assoc"},{"key":"96_CR42","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.kjms.2012.11.004","volume":"29","author":"M Eroglu","year":"2013","unstructured":"Eroglu M, Yilmaz N, Yalcinkaya S, Ay N, Aydin O, Sezer C. Enhanced HDL-cholesterol-associated anti-oxidant PON-1 activity in prostate cancer patients. Kaohsiung J Med Sci. 2013;29:368\u201373.","journal-title":"Kaohsiung J Med Sci"},{"key":"96_CR43","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/cncr.20905","volume":"103","author":"G Yang","year":"2005","unstructured":"Yang G, Timme TL, Frolov A, Wheeler TM, Thompson TC. Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression. Cancer. 2005;103:1186\u201394.","journal-title":"Cancer"},{"key":"96_CR44","unstructured":"ATP III At-A-Glance. Quick Desk Reference. In Book ATP III At-A-Glance: Quick Desk Reference (Editor ed.^eds.). City: National Institutes of Health; 2001."},{"key":"96_CR45","unstructured":"AJCC Cancer Staging Atlas A Companion to the Seventh Editions of the AJCC Cancer Staging Manual and Handbook Second Edition. In. 2nd Edition edition: Springer; 2012: 535\u2013546"},{"key":"96_CR46","first-page":"49","volume":"72","author":"RB Bendel","year":"1977","unstructured":"Bendel RB, Afifi AA. Comparison of stopping rules in forward regression. J Am Stat Assoc. 1977;72:49\u201353.","journal-title":"J Am Stat Assoc"},{"key":"96_CR47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/oxfordjournals.aje.a115101","volume":"129","author":"J Mickey","year":"1989","unstructured":"Mickey J, Greenland S. A study of the impact of confounder\u00ad selection criteria on effect estimation. Am J Epidemiol. 1989;129:125\u201337.","journal-title":"Am J Epidemiol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-015-0096-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T13:17:51Z","timestamp":1567171071000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.lipidworld.com\/content\/14\/1\/111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,17]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["96"],"URL":"https:\/\/doi.org\/10.1186\/s12944-015-0096-0","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,17]]},"article-number":"111"}}